Enhancing Oral Vaccine Potency by Targeting Intestinal M Cells
Authors:
Open Access
- 11 November 2010
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 6 (11) , e1001147
Abstract
The immune system in the gastrointestinal tract plays a crucial role in the control of infection, as it constitutes the first line of defense against mucosal pathogens. The attractive features of oral immunization have led to the exploration of a variety of oral delivery systems. However, none of these oral delivery systems have been applied to existing commercial vaccines. To overcome this, a new generation of oral vaccine delivery systems that target antigens to gut-associated lymphoid tissue is required. One promising approach is to exploit the potential of microfold (M) cells by mimicking the entry of pathogens into these cells. Targeting specific receptors on the apical surface of M cells might enhance the entry of antigens, initiating the immune response and consequently leading to protection against mucosal pathogens. In this article, we briefly review the challenges associated with current oral vaccine delivery systems and discuss strategies that might potentially target mouse and human intestinal M cells.Keywords
This publication has 107 references indexed in Scilit:
- Caveolae-mediated entry of Salmonella typhimurium in a human M-cell modelBiochemical and Biophysical Research Communications, 2009
- Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B–ESAT6 fusion proteinVaccine, 2009
- Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile ToxinPLOS ONE, 2009
- Oral vaccination with LcrV from Yersinia pestis KIM delivered by live attenuated Salmonellaenterica serovar Typhimurium elicits a protective immune response against challenge with Yersinia pseudotuberculosis and Yersinia enterocoliticaVaccine, 2009
- M-Cell Targeting of Whole Killed Bacteria Induces Protective Immunity against Gastrointestinal PathogensInfection and Immunity, 2009
- In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coliVaccine, 2009
- Oxidation‐specific epitopes are important targets of innate immunityJournal of Internal Medicine, 2008
- Oral Vaccination withSalmonella entericaas a Cruzipain-DNA Delivery System Confers Protective Immunity againstTrypanosoma cruziInfection and Immunity, 2008
- Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccinationProceedings of the National Academy of Sciences, 2007
- Expression of Specific Markers and Particle Transport in a New Human Intestinal M-Cell ModelBiochemical and Biophysical Research Communications, 2000